Longitudinal Outcomes in Hepatic Resection

Withdrawn

• Conditions: Liver Diseases; Surgery

• Registration Number: NCT02997098
• Lead Sponsor: Duke University

Brief Summary

This observational registry of patients undergoing liver surgery collects patients both retrospectively and prospectively. Patients undergoing liver resection for any non-transplant indication will be evaluated for clinical outcomes (such as surgical complications, survival, and disease progression) based on clinical and patient factors (like indication, age, and other treatments for the disease).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-12-15
• Study First Submitted QC: 2016-12-15
• Study First Posted: 2016-12-19
• Study Start: 2017-05-04
• Status Verified: 2018-07
• Last Update Submitted: 2018-07-27
• Last Update Posted: 2018-07-31
• Primary Completion: 2037-05
• Study Completion: 2037-05

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients requiring liver resection

Read More

Exclusion Criteria

• Patients under the age of 18 years
• Patients undergoing liver transplant

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival	10 years

Secondary Outcome Measures

Name	Time	Method
Intraoperative blood loss	1 day
Operative time	1 day
Number of segments resected	1 day	If applicable
Disease-free survival	10 years
Surgical-site infection	3 months
Postoperative bleeding	3 months
Blood clot	3 months
Use of other therapy	5 years	e.g., antibiotics in liver abscess, chemotherapy in liver cancer

Trial Locations

Locations (1)

Duke University Health System; 🇺🇸 Durham, North Carolina, United States